BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19908366)

  • 1. Identification of coordinately dysregulated subnetworks in complex phenotypes.
    Chowdhury SA; Koyutürk M
    Pac Symp Biocomput; 2010; ():133-44. PubMed ID: 19908366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subnetwork state functions define dysregulated subnetworks in cancer.
    Chowdhury SA; Nibbe RK; Chance MR; Koyutürk M
    J Comput Biol; 2011 Mar; 18(3):263-81. PubMed ID: 21385033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying stage-specific protein subnetworks for colorectal cancer.
    Erten S; Chowdhury SA; Guan X; Nibbe RK; Barnholtz-Sloan JS; Chance MR; Koyutürk M
    BMC Proc; 2012 Nov; 6 Suppl 7(Suppl 7):S1. PubMed ID: 23173715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying gene subnetworks associated with clinical outcome in ovarian cancer using Network Based Coalition Game.
    Razi A; Afghah F; Varadan V
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():6509-13. PubMed ID: 26737784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.
    Khunlertgit N; Yoon BJ
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):351. PubMed ID: 27766944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying dysregulated pathways in cancers from pathway interaction networks.
    Liu KQ; Liu ZP; Hao JK; Chen L; Zhao XM
    BMC Bioinformatics; 2012 Jun; 13():126. PubMed ID: 22676414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic context-specific subnetwork discovery from large interaction networks.
    Saha A; Tan AC; Kang J
    PLoS One; 2014; 9(1):e84227. PubMed ID: 24392115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Efficient Algorithm for Identifying Mutated Subnetworks Associated with Survival in Cancer.
    Sarkar A; Atay Y; Erickson AL; Arisi I; Saltini C; Kahveci T
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1582-1594. PubMed ID: 30990435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
    Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of significantly mutated subnetworks in the breast cancer genome.
    Ajwad R; Domaratzki M; Liu Q; Feizi N; Hu P
    Sci Rep; 2021 Jan; 11(1):642. PubMed ID: 33436820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSNFS: Gene subnetwork biomarker identification of lung cancer expression data.
    Doungpan N; Engchuan W; Chan JH; Meechai A
    BMC Med Genomics; 2016 Dec; 9(Suppl 3):70. PubMed ID: 28117655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NetMix: A Network-Structured Mixture Model for Reduced-Bias Estimation of Altered Subnetworks.
    Reyna MA; Chitra U; Elyanow R; Raphael BJ
    J Comput Biol; 2021 May; 28(5):469-484. PubMed ID: 33400606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent Subgraph Mining of Functional Interaction Patterns Across Multiple Cancers.
    Durmaz A; Henderson TAD; Bebek G
    Pac Symp Biocomput; 2021; 26():261-272. PubMed ID: 33691023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
    Huang C; Li R; Shi W; Huang Z
    Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
    Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
    Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.